Sustained-release bimatoprost (MediPrint Ophthalmics)

N/A

Report date: 2026/02/16 20:01:25

Base Information

Drug NameSustained-release bimatoprost (MediPrint Ophthalmics)
Drug Alias NameLL-BMT1
ClassificationSmall molecules
Mechanisms of ActionProstanoid receptor agonists
TargetsProstanoid receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMediPrint Ophthalmics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMediPrint Ophthalmics Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-Angle
Inactive IndicationsOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A